To define the mechanism by which catalytic activity of LZK maintains HNSCC cell survival, we first assessed the abundance of GOF-p53, a downstream target of LZK based on knockdown experiments (1). This evidence concerns the gene MAP3K13 and head and neck squamous cell carcinoma.